Dead Sea climatotherapy for vitiligo: A retrospective study of 436 patients

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 8, 2011, Pages 959-963

  Czarnowicki, T ^a,b   Harari, M ^a,b   Ruzicka, T ^a,b   Ingber, A ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

climatotherapy; Dead Sea; vitiligo

Indexed keywords

ADULT; ARTICLE; CLIMATOTHERAPY; COMPUTER AIDED DESIGN; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DEAD SEA CLIMATOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PIGMENT DISORDER; PRIORITY JOURNAL; REPIGMENTATION; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; SKIN DEFECT; SKIN PHOTOTYPE; SUN EXPOSURE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VITILIGO;

EID: 79960225857     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03903.x     Document Type: Article

References (27)

1. Ortonne J,. Vitiligo and other disorders of Hypopigmentation. In:, Bolognia J, Jorizzo J, Rapini R, eds. Dermatology. Vol 1. 2nd edn. Elsevier, Spain, 2008:65.
2. Kumari J,. Vitiligo treated with topical clobetasol propionate. Arch Dermatol 1984; 120: 631-635. (Pubitemid 14140281)
3. Gargoom AM, Duweb GA, Elzorghany AH, et al. Calcipotriol in the treatment of childhood vitiligo. Int J Clin Pharmacol Res 2004; 24: 11-14. (Pubitemid 39535380)
4. Lepe V, Moncada B, Castanedo-Cazares JP, et al. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003; 139: 581-585. (Pubitemid 36576373)
5. Schallreuter KU,. Effectiveness of pseudocatalase formulations in vitiligo. Clin Exp Dermatol 2003; 28: 562-563.
6. Abdulla SJ, Desgroseilliers JP,. Treatment of vitiligo with narrow-band ultraviolet B: advantages and disadvantages. J Cutan Med Surg 2008; 12: 174-179.
7. Bhatnagar A, Kanwar AJ, Parsad D, et al. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study. J Eur Acad Dermatol Venereol 2007; 21: 638-642. (Pubitemid 46916761)
8. Whitton ME, Ashcroft DM, González U,. Therapeutic interventions for vitiligo. J Am Acad Dermatol 2008; 59: 713-717.
9. Gawkrodger DJ, Ormerod AD, Shaw L, et al. Vitiligo: concise evidence based guidelines on diagnosis and management. Postgrad Med J 2010; 86: 466-471.
10. Harari M, Novack L, Barth J, et al. The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea. Int J Dermatol 2007; 46: 1087-1091. (Pubitemid 47506382)
11. Harari M, Shani J, Seidl V, et al. Climatotherapy of atopic dermatitis at the Dead Sea: demographic evaluation and cost-effectiveness. Int J Dermatol 2000; 39: 59-69. (Pubitemid 30113543)
12. Schallreuter KU, Moore J, Behrens-Williams S, et al. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 2002; 41: 482-487. (Pubitemid 35021486)
13. Fitzpatrick TB,. The validity and practicality of sun-reactive skin typesI-VI. Arch Dermatol 1988; 124: 869-871.
14. TaÃeb A, Picardo M,. Clinical practice. Vitiligo. N Engl J Med 2009; 360: 160-169.
15. Koga M, Tango T,. Clinical features and course of type A and type B vitiligo. Br J Dermatol 1988; 118: 223-228.
16. Taîeb A, Picardo M,. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007; 20: 27-35. (Pubitemid 46090162)
17. Kushelevsky AP, Harari M, Kudish AI, et al. Safety of solar phototherapy at the Dead Sea. J Am Acad Dermatol 1998; 38: 447-452. (Pubitemid 28125529)
18. Leibovici V, Sagi E, Siladji S, et al. Seasonal variations of UV radiation at the Dead Sea. Dermatologica 1987; 174: 290-292. (Pubitemid 17075442)
19. Livingston EH, Lee S,. Percentage of burned body surface area determination in obese and nonobese patients. J Surg Res 2000; 91: 106-110. (Pubitemid 30445582)
20. Kudish AI, Abels D, Harari M,. Ultraviolet radiation properties as applied to photoclimatherapy at the Dead Sea. Int J Dermatol 2003; 42: 359-365. (Pubitemid 36681717)
21. Ahmed I, Ahmed S, Nasreen S,. Frequency and pattern of psychiatric disorders in patients with vitiligo. JAyub Med Coll Abbottabad 2007; 19: 19-21.
22. Sukan M, Maner F,. The problems in sexual functions of vitiligo and chronic urticaria patients. J Sex Marital Ther 2007; 33: 55-64. (Pubitemid 44949972)
23. Falabella R, Barona MI,. Update on skin repigmentation therapies in vitiligo. Pigment Cell Melanoma Res 2009; 22: 42-65.
24. Westerhof W, Nieuweboer-Krobotova L,. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
25. Yones SS, Palmer RA, Garibaldinos TM, et al. Randomized Double-blind Trial of Treatment of Vitiligo: efficacy of psoralen-UV-A Therapy vsnarrowband-UV-B therapy. Arch Dermatol 2007; 143: 578-584. (Pubitemid 46799844)
26. Parsad D, Kanwar AJ, Kumar B,. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 175-177. (Pubitemid 43740518)
27. Bhatnagar A, Kanwar AJ, Parsad D, De D,. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. J Eur Acad Dermatol Venereol 2007; 21: 1381-1385. (Pubitemid 350020146)